ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

What is CRISPR and how does it work? – The Conversation AU

Continue reading

2018-01-31 Michael Zand NEWS

New gene therapy could cure a deadly disease that stops the heart from beating – The Verge

The VergeNew gene therapy could cure a deadly disease that stops the heart from beatingThe VergeScientists have successfully tweaked the DNA in human heart cells to correct mutations that cause a deadly disease. If the gene-editing technique is proven … Continue reading

2018-01-31 Michael Zand NEWS

Dense Tissue Is Not an Obstacle to Immunotherapy in Desmoplastic Melanoma – www.oncnursingnews.com/

Dense Tissue Is Not an Obstacle to Immunotherapy in Desmoplastic Melanomawww.oncnursingnews.com/“Often, combinations of two immunotherapy drugs are used to treat patients with melanoma to try to improve tumor response rates and survival about current r… Continue reading

2018-01-31 Michael Zand NEWS

Bayer Buys More Crispr Stock After Celgene Sells – Barron’s


The Conversation AU

What is CRISPR and how does it work?
The Conversation AU
CRISPR/Cas9 is a system found in bacteria and involved in immune defence. Bacteria use CRISPR/Cas9 to cut up the DNA of invading bacterial viruses that might otherwise kill them. Today we’ve adapted this molecular machinery for an entirely different …
CRISPR-Cas9 Corrects Mutations in Muscular Dystrophy Patients’ CellsTechnology Networks
New gene therapy could cure a deadly disease that stops the heart from beatingThe Verge

all 4 news articles »

Continue reading

2018-01-31 Michael Zand NEWS

Bayer Buys More Crispr Stock After Celgene Sells – Barron’s


Barron’s

Bayer Buys More Crispr Stock After Celgene Sells
Barron’s
A Bayer unit invested $12 million more in the Swiss firm right before a rally that saw the stock rocket. By. Ed Lin. Jan. 31, 2018 1:29 p.m. ET. By. Ed Lin. Jan. 31, 2018 1:29 p.m. ET. Crispr Therapeutics’ largest shareholder just invested another $12 …
Here’s Why Editas Medicine Rose as Much as 15.7% YesterdayMotley Fool
Reviewing Crispr Therapeutics (NASDAQ:CRSP) and Iqvia (IQV)The Ledger Gazette
Should You Invest in CRISPR Therapeutics AG (CRSP)? A Look at the Insider TrendsStockNewsGazette
Post Registrar –TrueBlueTribune
all 31 news articles »
Continue reading

2018-01-31 Michael Zand NEWS

Reading and writing DNA – MIT News

MIT NewsReading and writing DNAMIT NewsThanks to the invention of genome sequencing technology more than three decades ago, we can now read the genetic blueprint of virtually any organism. After the ability to read came the ability to edit — adding, su… Continue reading

2018-01-31 Michael Zand NEWS

Researchers Identify Novel Drivers of Cancer Stem Cells That Lead to Colon Cancer Development and Growth – Newswise (press release)


Barron’s

Bayer Buys More Crispr Stock After Celgene Sells
Barron’s
Both Bayer and Celgene invested in Crispr before the company went public. A Bayer unit agreed in December 2015 to create a joint venture to discover and commercialize therapeutics to treat blood disorders, blindness and heart disease, other indications …
Reviewing Crispr Therapeutics (NASDAQ:CRSP) and Iqvia (IQV)The Ledger Gazette
Should You Invest in CRISPR Therapeutics AG (CRSP)? A Look at the Insider TrendsStockNewsGazette
Analysts’ Views: Government Properties Income Trust (GOV) and Crispr Therapeutics Ag (CRSP)Post Registrar
Madison.com –Post Analyst –TrueBlueTribune
all 33 news articles »
Continue reading

2018-01-31 Michael Zand NEWS

Immunotherapy Active in Advanced GISTs – OncLive

OncLiveImmunotherapy Active in Advanced GISTsOncLiveDo these findings suggest a future for immunotherapy in patients with GISTs? At this point, they do suggest that immunotherapy has a role in GIST. We still have another 20 patients to put onto the tri… Continue reading

2018-01-31 Michael Zand NEWS
  • 1
  • …
  • 591
  • 592
  • 593
  • 594
  • 595
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Researchers Identify Novel Drivers of Cancer Stem Cells That Lead to Colon Cancer Development and Growth
Newswise (press release)
Newswise — Wilmington, Del., Jan 30, 2018 – In breakthrough colon cancer research, scientists at Christiana Care Health System’s Center for Translational Cancer Research (CTCR) of the Helen F. Graham Cancer Center & Research Institute have discovered …

and more »